Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy

References

• Franks S. Polycystic ovary syndrome. N Engl J Med 1995; 333: 853–861
   PubMed Web of Science ®Google Scholar
• Homburg R, Armar N A, Eshel A, Adams J, Jacobs H S. Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome. BMJ 1988; 297: 1024–1026
   PubMed Web of Science ®Google Scholar
• Sagle M, Bishop K, Ridley N, Alexander F M, Michel M, Bonney R C, Beard R W, Franks S. Recurrent early miscarriage and polycystic ovaries. BMJ 1988; 297: 1027–1028
   PubMed Web of Science ®Google Scholar
• Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001; 16: 226–229
   PubMed Web of Science ®Google Scholar
• de Vries M J, Dekker G A, Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol 1998; 76: 91–95
   PubMed Web of Science ®Google Scholar
• Bjercke S, Dale P O, Tanbo T, Storeng R, Ertzeid G, Abyholm T. Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome. Gynecol Obstet Invest 2002; 54: 94–98
   PubMed Web of Science ®Google Scholar
• Radon P A, McMahon M J, Meyer W R. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999; 94: 194–197
   PubMed Web of Science ®Google Scholar
• Lord J M, Flight I H, Norman R J. Metformin in polycystic ovary syndrome: Systematic review and meta-analysis. BMJ 2003; 327: 951–953
   PubMed Web of Science ®Google Scholar
• McCarthy E A, Walker S P, McLachlan K, Boyle J, Permezel M. Metformin in obstetric and gynecologic practice: A review. Obstet Gynecol Surv 2004; 59: 118–127
   PubMed Web of Science ®Google Scholar
• Lord J M, Flight I H, Norman R J. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev 2003, CD003053
   PubMedGoogle Scholar
• Glueck C J, Phillips H, Cameron D, Sieve-Smith L, Wang P. Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: A pilot study. Fertil Steril 2001; 75: 46–52
   PubMed Web of Science ®Google Scholar
• Jakubowicz D J, Iuorno M J, Jakubowicz S, Roberts K A, Nestler J E. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 524–529
   PubMed Web of Science ®Google Scholar
• Glueck C J, Wang P, Goldenberg N, Sieve-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002; 17: 2858–2864
   PubMed Web of Science ®Google Scholar
• Glueck C J, Wang P, Kobayashi S, Phillips H, Sieve-Smith L. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome. Fertil Steril 2002; 77: 520–525
   PubMed Web of Science ®Google Scholar
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19–25
   PubMed Web of Science ®Google Scholar
• Legro R S, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694–2698
   PubMed Web of Science ®Google Scholar
• Fenton T R. A new growth chart for preterm babies: Babson and Benda's chart updated with recent data and a new format. BMC Pediatr 2003; 3: 13
   PubMed Web of Science ®Google Scholar
• Oken E, Kleinman K P, Rich-Edwards J, Gillman M W. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr 2003; 3: 6
   PubMedGoogle Scholar
• Briggs G G, Freeman R K, Yaffe S J. Drugs in pregnancy and lactation. Lippincott Williams & Wilkins, Baltimore, MDUSA 2002
   Google Scholar
• Glueck C J, Goldenberg N, Pranikoff J, Loftspring M, Sieve L, Wang P. Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004; 19: 1323–1330
   PubMed Web of Science ®Google Scholar
• Vanky E, Salvesen K A, Heimstad R, Fougner K J, Romundstad P, Carlsen S M. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: Results of a randomized study. Hum Reprod 2004; 19: 1734–1740
   PubMed Web of Science ®Google Scholar
• Giudice L C, de Zegher F, Gargosky S E, Dsupin B A, de las Fuentes Z, Crystal R A, Hintz R L, Rosenfeld R G. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995; 80: 1548–1555
   PubMed Web of Science ®Google Scholar
• Hill D J, Tevaarwerk G J, Caddell C, Arany E, Kilkenny D, Gregory M. Fibroblast growth factor 2 is elevated in term maternal and cord serum and amniotic fluid in pregnancies complicated by diabetes: Relationship to fetal and placental size. J Clin Endocrinol Metab 1995; 80: 2626–2632
   PubMed Web of Science ®Google Scholar
• Norman R J, Wang J X, Hague W. Should we continue or stop insulin sensitizing drugs during pregnancy?. Curr Opin Obstet Gynecol 2004; 16: 245–250
   PubMed Web of Science ®Google Scholar